cannabinoid similar to THC included in an FDA-approved pharmaceutical; a Schedule II controlled substance under the CSA Nasdaq Nasdaq Stock Market NDA New Drug Application; an application submitted by a drug manufacturer to the FDA for approval of a drug NYSE New York Stock Exchange 172 @ 2017 Ackrell Capital, LLC | M